Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
一线治疗上皮性卵巢癌、输卵管癌或原发性腹膜癌的每周高剂量化疗(ICON8):一项GCIG 3期随机对照试验的主要无进展生存期分析结果
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(19)32259-7
Clamp, Andrew R; James, Elizabeth C; McNeish, Iain A; Dean, Andrew; Kim, Jae-Weon; O'Donnell, Dearbhaile M; Hook, Jane; Coyle, Christopher; Blagden, Sarah; Brenton, James D; Naik, Raj; Perren, Tim; Sundar, Sudha; Cook, Adrian D; Gopalakrishnan, Gosala S; Gabra, Hani; Lord, Rosemary; Dark, Graham; Earl, Helena M; Hall, Marcia; Banerjee, Susana; Glasspool, Rosalind M; Jones, Rachel; Williams, Sarah; Swart, Ann Marie; Stenning, Sally; Parmar, Mahesh; Kaplan, Richard; Ledermann, Jonathan A